177Lu-FAP-2286 Therapy in a Case of Squamous Lung Cancer

We reported a 72-year-old man who was diagnosed with squamous lung cancer and received 2 cycles of 177 Lu-FAP-2286 treatment. Radiological remission was observed on follow-up FAP imaging 7 months later with squamous cell carcinoma antigen decreased to normal level. No other abnormality monitored by...

Full description

Saved in:
Bibliographic Details
Published in:Clinical nuclear medicine 2025-01, Vol.50 (1), p.103-104
Main Authors: Li, Linwei, Chen, Lingzhi, Zhang, Yanlang, Zhang, Yu, Chen, Yue
Format: Article
Language:English
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We reported a 72-year-old man who was diagnosed with squamous lung cancer and received 2 cycles of 177 Lu-FAP-2286 treatment. Radiological remission was observed on follow-up FAP imaging 7 months later with squamous cell carcinoma antigen decreased to normal level. No other abnormality monitored by routine laboratory examination was noted.
ISSN:0363-9762
1536-0229
DOI:10.1097/RLU.0000000000005489